ArcticZymes Technologies ASA (OSL:AZT)
Norway
· Delayed Price · Currency is NOK 19.90
-1.10 (-5.24%)
At close: Dec 5, 2025
OSL:AZT Revenue
ArcticZymes Technologies ASA had revenue of 29.77M NOK in the quarter ending September 30, 2025, with 23.45% growth. This brings the company's revenue in the last twelve months to 109.99M, down -0.70% year-over-year. In the year 2024, ArcticZymes Technologies ASA had annual revenue of 108.11M, down -9.65%.
Revenue (ttm)
109.99M
Revenue Growth
-0.70%
P/S Ratio
9.24
Revenue / Employee
2.08M
Employees
54
Market Cap
1.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 108.11M | -11.54M | -9.65% |
| Dec 31, 2023 | 119.65M | -18.02M | -13.09% |
| Dec 31, 2022 | 137.67M | 6.62M | 5.05% |
| Dec 31, 2021 | 131.05M | 33.23M | 33.96% |
| Dec 31, 2020 | 97.82M | 48.65M | 98.92% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 662.18M |
| Nordhealth AS | 590.33M |
| Photocure ASA | 537.59M |
| Omda AS | 476.29M |
| Vistin Pharma ASA | 455.25M |
| Gentian Diagnostics ASA | 172.52M |
| Nykode Therapeutics AS | 73.37M |
| Lytix Biopharma AS | 377.00K |